Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor Expression
USC is a biologically heterogeneous disease, and its treatment should be guided by its molecular profile. ER expression identifies a subset of patients with improved DFS, suggesting potential prognostic relevance in this high-risk histology.
Authors
- Dimitrios Haidopoulos (ORCID: https://orcid.org/0000-0001-9366-9691)
- Anna Svarna (ORCID: https://orcid.org/0000-0002-7897-0272)
- K. Goula
- Maria Kaparelou
- Constantine Dimitrakakis (ORCID: https://orcid.org/0000-0002-4615-1969)
- Katerina Aravantinou
- Ioanna Kollarou
- Michalis Liontos
- Flora Zagouri
- Konstantinos Koutsoumpogeras
- Konstantina Christina Perdikari
- Konstantina Pardali
- Meletios Athanasios Dimopoulos
Institutions
- Korea University (KR)
- National and Kapodistrian University of Athens (GR)
- Alexandra Hospital (GR)
- Aretaeio Hospital (GR)
Publication Details
- Journal
- Current Oncology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.3390/curroncol33030132
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00